Literature DB >> 19477423

Mammary tumorigenesis through LPA receptor signaling.

Jos Jonkers1, Wouter H Moolenaar.   

Abstract

Lysophosphatidic acid (LPA) is a lipid growth factor that is produced by an extracellular phospholipase, termed autotaxin (ATX), and acts via G protein-coupled receptors. In this issue of Cancer Cell, Liu et al. show that transgenic overexpression of ATX or LPA receptors leads to invasive and metastatic mammary cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19477423     DOI: 10.1016/j.ccr.2009.05.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  11 in total

1.  Lipid Signaling in Tumorigenesis.

Authors:  Renyan Liu; Ying Huang
Journal:  Mol Cell Pharmacol       Date:  2014-01-01

Review 2.  Role of autotaxin in cancer stem cells.

Authors:  Dongjun Lee; Dong-Soo Suh; Sue Chin Lee; Gabor J Tigyi; Jae Ho Kim
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

3.  New members of the mammalian glycerophosphodiester phosphodiesterase family: GDE4 and GDE7 produce lysophosphatidic acid by lysophospholipase D activity.

Authors:  Noriyasu Ohshima; Takahiro Kudo; Yosuke Yamashita; Stefania Mariggiò; Mari Araki; Ayako Honda; Tomomi Nagano; Chiaki Isaji; Norihisa Kato; Daniela Corda; Takashi Izumi; Noriyuki Yanaka
Journal:  J Biol Chem       Date:  2014-12-20       Impact factor: 5.157

4.  TNFAIP8: a new effector for Galpha(i) coupling to reduce cell death and induce cell transformation.

Authors:  Benoit Laliberté; Ariel M Wilson; Houman Nafisi; Helen Mao; Yi Yuen Zhou; Mireille Daigle; Paul R Albert
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

Review 5.  Integrated gene networks in breast cancer development.

Authors:  Ivana Ratkaj; Emil Stajduhar; Srdan Vucinic; Sime Spaventi; Hrvojka Bosnjak; Kresimir Pavelic; Sandra Kraljevic Pavelic
Journal:  Funct Integr Genomics       Date:  2010-02-04       Impact factor: 3.410

6.  CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model.

Authors:  Y Ward; R Lake; P L Martin; K Killian; P Salerno; T Wang; P Meltzer; M Merino; S-y Cheng; M Santoro; G Garcia-Rostan; K Kelly
Journal:  Oncogene       Date:  2012-07-16       Impact factor: 9.867

Review 7.  LPA receptor signaling: pharmacology, physiology, and pathophysiology.

Authors:  Yun C Yung; Nicole C Stoddard; Jerold Chun
Journal:  J Lipid Res       Date:  2014-03-18       Impact factor: 5.922

8.  Stat3 mediates expression of autotaxin in breast cancer.

Authors:  Janeen Azare; Ashley Doane; Kenneth Leslie; Qing Chang; Marjan Berishaj; Jennifer Nnoli; Kevin Mark; Hikmat Al-Ahmadie; William Gerald; Maryam Hassimi; Agnes Viale; Mary Stracke; David Lyden; Jacqueline Bromberg
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

Review 9.  PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance.

Authors:  Robert I Glazer
Journal:  PPAR Res       Date:  2016-12-18       Impact factor: 4.964

10.  Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells.

Authors:  Chuan-En Lin; Shee-Uan Chen; Chu-Cheng Lin; Chi-Hao Chang; Yueh-Chien Lin; Yu-Ling Tai; Tang-Long Shen; Hsinyu Lee
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.